Immunohistochemical detection of estrogen receptor alpha in pituitary adenomas and its correlation with cellular replication

Neuroendocrinology

Volumn 79, Issue 3, 2004, Pages 119-124

  Pereira Lima, Julia F S ^a   Marroni, Caroline P ^a   Pizarro, Cristina B ^a   Barbosa Coutinho, Ligia M ^a   Ferreira, Nelson P ^a   Oliveira, Miriam C ^a,b  

^a General and Experimental Pathology   (Brazil)

^b NONE   (Brazil)

Author keywords

Cell proliferation; Clinical neuroendocrinology; Gonadal steroid receptors; Immunohistochemistry; Pituitary adenomas

Indexed keywords

CORTICOTROPIN; ESTROGEN RECEPTOR ALPHA; FOLLITROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; PROLACTIN;

ACROMEGALY; ADULT; ARTICLE; AUTOPSY; CARCINOGENESIS; CELL DIVISION; CELL LABELING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; CUSHING SYNDROME; FEMALE; HORMONE ACTION; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROADENOMA; NEUROIMAGING; PHENOTYPIC VARIATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADENOMA; ADULT; CELL DIVISION; CROSS-SECTIONAL STUDIES; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES;

EID: 2342571128     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077269     Document Type: Article

References (43)

1. Wiedemann E, Schwartz E, Franz AG: Acute and chronic effects upon somatomedin C activity, growth hormone and prolactin in man. J Clin Endocrinol Metab 1975;42:942-950.
2. Veldhuis JD, Samjlik E, Evans WS, Rogol AD, Ridgeway LE, Crowley WF, Kolp L, Checiniska E, Kirschner MA, Thorner MO: Endocrine impact of pure estradiol replacement in postmenopausal women: Alterations in anterior pituitary hormone release and circulating sex steroid hormone concentration. Am J Obstet Gynecol 1986;155:334-339.
3. Shupnik MA, Gharib SD, Chin WW: Divergent effects of estradiol on gonadotropin gene transcription in pituitary fragments. Mol Endocrinol 1989;3:474-480.
4. Burgess LH, Handa RJ: Chronic estrogen-induced alterations in adrenocorticotropic and corticosterone secretion and glucocorticoid receptor-mediated functions in female rats. Endocrinology 1992;131:1261-1269.
5. Kineman RD, Faught WJ, Frawley LS: Steroids can modulate transdifferentiation of prolactin and growth hormone cells in bovine pituitary cultures. Endocrinology 1992;130:3289-3294.
6. Chaidarun SS, Eggo MC, Stewart PM, Barber PC, Sheppard MC: Role of growth factors and estrogen as modulators and growth differentiation and expression of gonadotropin subunit genes in primary cultures sheep pituitary cells. Endocrinology 1994;134:935-944.
7. Jaffrain-Rea ML, Petrageli E, Ortolani F, Fraioli B, Lise A, Esposito V, Spagnoli LG, Tamburrano G, Frati L, Gulino A: Cellular receptors for sex steroids in human pituitary adenomas. J Endocrinol 1996;151:175-184.
8. Oliveira MC, Messinger HP, Tannhauser M, Barbosa-Coutinho LM: Chronic effect of antidopamiergic drugs or estrogen on male Wistar rat lactotrophs and somatotrophs. Braz J Med Biol Res 1999;32:1561-1564.
9. Shupnik MA, Pitt LK, Soh AY, Anderson A, Lopes MB, Laws ER Jr: Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors. J Clin Endocrinol Metab 1998;83:3965-3972.
10. Behncken A, Saeger W: Lectin-bindings in pituitary adenomas and normal pituitaries. Pathol Res Pract 1991;187:629-631.
11. Nakao H, Koga M, Areao M, Nakao M, Sato B, Kishmoto S, Saiotoh Y, Arita N, Mori S: Enzyme-immunoassay for estrogen receptors in human pituitary adenomas. Acta Endocrinol 1989;120:133-138.
12. Zafar M, Ezzat S, Ramyar L, Pan N, Smyth HS, Asa SL: Cell-specific expression of estrogen receptor in the human pituitary and its adenomas. J Clin Endocrinol Metab 1995;80:3621-3627.
13. Gittoes NJL, McCabe CJ, Verhaeg J, Sheppard MC, Franklyn JA: Thyroid hormone and estrogen receptor expression in normal pituitary and nonfunctioning tumors of the anterior pituitary. J Clin Endocrinol Metab 1997;82:1960-1967.
14. Friend KE, Chiou YK, Lopes MBS, Laws ER Jr, Hughes KM, Shupnik MA: Estrogen receptor expression in human pituitary: Correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas. J Clin Endocrinol Metab 1994;78:1497-1504.
15. Stefaneanu L, Kovacs K, Horvarth E, Lloyd RV, Buchfelder M, Fahlbusch R, Smyth H: In situ hybridization study of estrogen receptor messenger ribonucleid acid in human adenohypophysial cells and pituitary adenomas. J Clin Endocrinol Metab 1994;78:83-88.
16. Bruno S, Dazynkiewicz Z: Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody and HL-60 cells. Cell Prolif 1992;25:31-40.
17. Cattoretti G, Becker MHG, Key G, Duchrow M Schlüter C, Galle J, Gerdes J: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detecting proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-363.
18. Gerdes J, Becker MHG, Key G, Cattoretti G: Immunohistologic detection of tumor growth fraction (Ki-67) in formalin fixed and routinely processed tissue. J Pathol 1992;168:85-87.
19. McCormick CY, Yu C, Hobbs C, Hall PA: The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens. Histopathology 1993;22:543-547.
20. Schwarting R: Little missed markers and Ki-67. Lab Invest 1993;68:597-599.
21. De Mello ES, Alves VAF: Manual de Imuno-Histoquímica; in Alves VAF (ed): Marcadores de proliferação celular. São Paulo, Editora da Sociedade Brasileira de Patologia, 1999, pp 182-194.
22. Landolt AM, Shibata T, Kleihues P: Growth rate of human pituitary adenomas. J Neurosurg 1987;67:803-806.
23. Knosp E, Kitz K, Perneczky A: Proliferation activity in pituitary adenomas: Measurement by monoclonal antibody Ki-67. Neurosurgery 1989;25:927-930.
24. Shibuya M, Saito F, Miwa T, Davis RL, Wilson CB, Hoshino T: Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts. Acta Neuropathol (Berlin) 1992;84:178-183.
25. Knosp E, Steiner E, Kitz K, Matula C: Pituitary adenomas with invasion of the cavernous sinus space: A magnetic resonance imaging classification compared with surgical findings. Neurosurgery 1993;33:610-617.
26. Gandour-Edwards R, Kapadis SB, Janecka IP, Barnes L: Biologic markers of invasive pituitary adenomas involving the sphenoid sinus. Mod Pathol 1995;8:160-164.
27. Pizarro CB, Oliveira MC, Coutinho LMB, Ferreira NP: Measurement of Ki-67 antigen in 159 pituitary adenomas using MIB-1 monoclonal antibody. Braz J Med Biol Res 2004;37:235-243.
28. Kovacs K, Horvath E: Tumors of the pituitary gland; in Hartmann WH (ed): Atlas of Tumor Pathology. Washington, Armed Forces Institute of Pathology, 1986, fasc 21, ser 2, pp 1-264.
29. Andersen J, Orntoft TF, Poulsen HS: Immunohistochemical demonstration of estrogen receptors (ER) in formalin-fixed, paraffin-embedded human breast cancer tissue by use of a monoclonal antibody to ER. J Histochem Cytochem 1988;36:1553-1560.
30. Paterson DA, Reid CP, Anderson TJ, Hawkins RA: Assessment of oestrogen receptor content of breast carcinoma by immunohistochemical techniques on fixed and frozen tissue and by biochemical ligand binding assay. J Clin Pathol 1990;43:46-51.
31. Kovacs K, Horvath E, Vidal S: Classification of pituitary adenomas. J Neurooncol 2001;54:127-137.
32. Stefaneanu L, Kovacs K: Immunocytochemical approach to demonstrate the estrogen receptor in human adenohypophyses and pituitary adenomas with monoclonal antibody. Med Sci Res 1988;16:449-450.
33. Ironside JW, Dangerfield VJM, Timperlay WR, Underwood JCE: Steroid hormone receptors in pituitary adenomas: A biochemical, immunohistochemical and morphometric study on cryostat sections. Neuropathol Appl Neurobiol 1986;12:5539-5546.
34. Chaidarun SS, Klibanski AA, Alexander JM: Tumor-specific expression of alternatively spliced estrogen receptor messenger ribonucleic acid variants in human pituitary adenomas. J Clin Endocrinol Metab 1997;82:1058-1065.
35. Pichon MF, Bression D, Peillon F, Milgrom E: Estrogen receptors in human pituitary adenomas. J Clin Endocrinol Metab 1980;51:897-902.
36. Sanno N, Teramoto A, Matsuno A, Takekoshi S, Itoh J, Osamura Y: Expression of Pit-1 and estrogen receptor messenger RNA in prolactin-producing pituitary adenomas. Mod Pathol 1996;9:526-533.
37. Calle-Rodrigues RDP, Giannini C, Scheithauer BW, Lloyd RV, Wollan PC, Kovacs KT, Stefaneanu L, Ebright AB, Abboud CF, Davis DH: Prolactinomas in male and female patients: A comparative clinicopathologic study. Mayo Clin Proc 1998;73:1046-1052.
38. Kaptain GJ, Simmons NE, Alden TD, Lopes MB, Vance ML, Laws ER Jr: Estrogen receptors in prolactinomas: A clinico-pathological study. Pituitary 1999;1:91-98.
39. Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D, Laws ER Jr: Proliferative activity and invasiveness among pituitary adenomas and carcinomas: An analysis using the MIB-1 antibody. Neurosurgery 1996;38:99-107.
40. Buchfelder M, Fahlbusch R, Adams EF, Kiesewetter F, Thierauf P: Proliferation parameters for pituitary adenomas. Acta Neurochir (Wien) 1996;65:18-21.
41. Asa SL, Cheng Z, Ramyar L, Kovacs L, Smyth HS, Muller P: Human pituitary null cell adenomas and oncocytomas in vitro: Effects of adenohypophysiotropic hormones and gonadal steroids on hormone secretion and tumor cell morphology. J Clin Endocrinol Metab 1992;74:1128-1137.
42. Haug E, Gautvik KM: Effects of sex steroids on prolactin secreting rat pituitary cells in culture. Endocrinology 1976;99:1482-1489.
43. Caronti B, Palladini G, Caldelaro C, Bevilacqua MG, Petrangeli E, Esposito V, Tamburrano G, Gulino A, Jaffrain-Rea ML: Effects of gonadal steroids on the growth of human pituitary adenomas in vitro. Tumor Biol 1995;16:353-364.